Biosensors
Introduction
e2v has invented a novel biosensor platform, that it plans to bring to the medical diagnostics and life science markets. It will initially be developed for protein quantification on a point of care platform. The technology combines the advantages of sensitivity from Surface Enhanced Resonance Raman Spectroscopy (SERRS) with a proprietary displacement assay using a single antibody. The platform comprises a disposable chip that includes all of the reagents, is simple to use, and provides results in less than 10 minutes.
The SERRS technology allows detection of proteins at very low concentrations. This, coupled with its single antibody structure, enables quantification of biomarkers that are not easily measured on other platforms.
The system offers several unique advantages over other systems available for biomarker point of care analysis. It combines a multiplex capability, high sensitivity and high specificity, with a simple user protocol. e2v biosensors has secured substantial intellectual property through 2 issued patent families and a further 11 pending.